nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—ADRA1B—vas deferens—prostate cancer	0.094	0.579	CbGeAlD
Fenoldopam—ADRA1D—prostate gland—prostate cancer	0.00821	0.0506	CbGeAlD
Fenoldopam—ADRA1D—epithelium—prostate cancer	0.00603	0.0372	CbGeAlD
Fenoldopam—ADRA1B—renal system—prostate cancer	0.00572	0.0352	CbGeAlD
Fenoldopam—ADRA1D—urethra—prostate cancer	0.0055	0.0338	CbGeAlD
Fenoldopam—ADRA1A—prostate gland—prostate cancer	0.00471	0.029	CbGeAlD
Fenoldopam—ADRA2C—prostate gland—prostate cancer	0.00449	0.0277	CbGeAlD
Fenoldopam—ADRA2C—seminal vesicle—prostate cancer	0.0038	0.0234	CbGeAlD
Fenoldopam—ADRA2A—prostate gland—prostate cancer	0.00358	0.0221	CbGeAlD
Fenoldopam—ADRA1A—epithelium—prostate cancer	0.00346	0.0213	CbGeAlD
Fenoldopam—ADRA1A—renal system—prostate cancer	0.00321	0.0198	CbGeAlD
Fenoldopam—ADRA2C—renal system—prostate cancer	0.00306	0.0189	CbGeAlD
Fenoldopam—ADRA2A—seminal vesicle—prostate cancer	0.00303	0.0187	CbGeAlD
Fenoldopam—ADRA2C—urethra—prostate cancer	0.00301	0.0185	CbGeAlD
Fenoldopam—ADRA2A—urethra—prostate cancer	0.0024	0.0148	CbGeAlD
Fenoldopam—DRD2—testis—prostate cancer	0.00204	0.0125	CbGeAlD
Fenoldopam—ADRA2C—testis—prostate cancer	0.00198	0.0122	CbGeAlD
Fenoldopam—ADRA2A—testis—prostate cancer	0.00158	0.00973	CbGeAlD
Fenoldopam—ADRA2C—lymph node—prostate cancer	0.00143	0.00884	CbGeAlD
Fenoldopam—ADRA2A—lymph node—prostate cancer	0.00114	0.00705	CbGeAlD
Fenoldopam—Chest pain—Goserelin—prostate cancer	0.000994	0.00174	CcSEcCtD
Fenoldopam—Haemorrhage—Mitoxantrone—prostate cancer	0.000991	0.00173	CcSEcCtD
Fenoldopam—Anxiety—Goserelin—prostate cancer	0.00099	0.00173	CcSEcCtD
Fenoldopam—Constipation—Ethinyl Estradiol—prostate cancer	0.00099	0.00173	CcSEcCtD
Fenoldopam—Flushing—Estradiol—prostate cancer	0.000987	0.00173	CcSEcCtD
Fenoldopam—Chest pain—Conjugated Estrogens—prostate cancer	0.000984	0.00172	CcSEcCtD
Fenoldopam—Cardiac failure—Capecitabine—prostate cancer	0.000982	0.00172	CcSEcCtD
Fenoldopam—Anxiety—Conjugated Estrogens—prostate cancer	0.000981	0.00172	CcSEcCtD
Fenoldopam—Creatinine increased—Epirubicin—prostate cancer	0.000966	0.00169	CcSEcCtD
Fenoldopam—Nausea—Cabazitaxel—prostate cancer	0.000948	0.00166	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Ethinyl Estradiol—prostate cancer	0.000947	0.00166	CcSEcCtD
Fenoldopam—Diarrhoea—Bicalutamide—prostate cancer	0.000937	0.00164	CcSEcCtD
Fenoldopam—Tachycardia—Goserelin—prostate cancer	0.00093	0.00163	CcSEcCtD
Fenoldopam—Oliguria—Doxorubicin—prostate cancer	0.000923	0.00162	CcSEcCtD
Fenoldopam—Hyperhidrosis—Goserelin—prostate cancer	0.000921	0.00161	CcSEcCtD
Fenoldopam—Tachycardia—Conjugated Estrogens—prostate cancer	0.000921	0.00161	CcSEcCtD
Fenoldopam—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.000915	0.0016	CcSEcCtD
Fenoldopam—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000915	0.0016	CcSEcCtD
Fenoldopam—Injection site reaction—Epirubicin—prostate cancer	0.000914	0.0016	CcSEcCtD
Fenoldopam—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.000912	0.0016	CcSEcCtD
Fenoldopam—Tension—Estradiol—prostate cancer	0.000908	0.00159	CcSEcCtD
Fenoldopam—Dizziness—Bicalutamide—prostate cancer	0.000906	0.00159	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Etoposide—prostate cancer	0.000905	0.00158	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Docetaxel—prostate cancer	0.000904	0.00158	CcSEcCtD
Fenoldopam—Myocardial infarction—Etoposide—prostate cancer	0.0009	0.00157	CcSEcCtD
Fenoldopam—Nervousness—Estradiol—prostate cancer	0.000899	0.00157	CcSEcCtD
Fenoldopam—Blood creatinine increased—Capecitabine—prostate cancer	0.000898	0.00157	CcSEcCtD
Fenoldopam—Back pain—Estradiol—prostate cancer	0.000895	0.00157	CcSEcCtD
Fenoldopam—Creatinine increased—Doxorubicin—prostate cancer	0.000894	0.00156	CcSEcCtD
Fenoldopam—Hypotension—Goserelin—prostate cancer	0.00089	0.00156	CcSEcCtD
Fenoldopam—Muscle spasms—Estradiol—prostate cancer	0.00089	0.00156	CcSEcCtD
Fenoldopam—Hypotension—Conjugated Estrogens—prostate cancer	0.000882	0.00154	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Capecitabine—prostate cancer	0.000875	0.00153	CcSEcCtD
Fenoldopam—Cardiac failure—Prednisone—prostate cancer	0.000875	0.00153	CcSEcCtD
Fenoldopam—Hypokalaemia—Capecitabine—prostate cancer	0.000872	0.00153	CcSEcCtD
Fenoldopam—Vomiting—Bicalutamide—prostate cancer	0.000871	0.00152	CcSEcCtD
Fenoldopam—Blood urea increased—Epirubicin—prostate cancer	0.000868	0.00152	CcSEcCtD
Fenoldopam—Insomnia—Goserelin—prostate cancer	0.000862	0.00151	CcSEcCtD
Fenoldopam—Headache—Bicalutamide—prostate cancer	0.000858	0.0015	CcSEcCtD
Fenoldopam—Insomnia—Conjugated Estrogens—prostate cancer	0.000854	0.00149	CcSEcCtD
Fenoldopam—Dyspnoea—Goserelin—prostate cancer	0.000849	0.00149	CcSEcCtD
Fenoldopam—Injection site reaction—Doxorubicin—prostate cancer	0.000846	0.00148	CcSEcCtD
Fenoldopam—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000841	0.00147	CcSEcCtD
Fenoldopam—Back pain—Mitoxantrone—prostate cancer	0.000834	0.00146	CcSEcCtD
Fenoldopam—Angina pectoris—Docetaxel—prostate cancer	0.000833	0.00146	CcSEcCtD
Fenoldopam—Palpitations—Estradiol—prostate cancer	0.000818	0.00143	CcSEcCtD
Fenoldopam—Constipation—Goserelin—prostate cancer	0.000815	0.00143	CcSEcCtD
Fenoldopam—Nausea—Bicalutamide—prostate cancer	0.000814	0.00142	CcSEcCtD
Fenoldopam—Constipation—Conjugated Estrogens—prostate cancer	0.000807	0.00141	CcSEcCtD
Fenoldopam—Angina pectoris—Capecitabine—prostate cancer	0.000807	0.00141	CcSEcCtD
Fenoldopam—Blood urea increased—Doxorubicin—prostate cancer	0.000803	0.00141	CcSEcCtD
Fenoldopam—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000792	0.00139	CcSEcCtD
Fenoldopam—Chest pain—Estradiol—prostate cancer	0.000788	0.00138	CcSEcCtD
Fenoldopam—Anxiety—Estradiol—prostate cancer	0.000785	0.00137	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Goserelin—prostate cancer	0.000779	0.00136	CcSEcCtD
Fenoldopam—Hypokalaemia—Prednisone—prostate cancer	0.000777	0.00136	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000772	0.00135	CcSEcCtD
Fenoldopam—Dizziness—Ethinyl Estradiol—prostate cancer	0.000766	0.00134	CcSEcCtD
Fenoldopam—Flushing—Etoposide—prostate cancer	0.000765	0.00134	CcSEcCtD
Fenoldopam—Body temperature increased—Goserelin—prostate cancer	0.000753	0.00132	CcSEcCtD
Fenoldopam—Abdominal pain—Goserelin—prostate cancer	0.000753	0.00132	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Docetaxel—prostate cancer	0.000752	0.00132	CcSEcCtD
Fenoldopam—Myocardial infarction—Docetaxel—prostate cancer	0.000748	0.00131	CcSEcCtD
Fenoldopam—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000746	0.00131	CcSEcCtD
Fenoldopam—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000746	0.00131	CcSEcCtD
Fenoldopam—Tachycardia—Estradiol—prostate cancer	0.000737	0.00129	CcSEcCtD
Fenoldopam—Vomiting—Ethinyl Estradiol—prostate cancer	0.000736	0.00129	CcSEcCtD
Fenoldopam—Chest pain—Mitoxantrone—prostate cancer	0.000734	0.00128	CcSEcCtD
Fenoldopam—Anxiety—Mitoxantrone—prostate cancer	0.000732	0.00128	CcSEcCtD
Fenoldopam—Hyperhidrosis—Estradiol—prostate cancer	0.00073	0.00128	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Capecitabine—prostate cancer	0.000728	0.00127	CcSEcCtD
Fenoldopam—Headache—Ethinyl Estradiol—prostate cancer	0.000725	0.00127	CcSEcCtD
Fenoldopam—Myocardial infarction—Capecitabine—prostate cancer	0.000724	0.00127	CcSEcCtD
Fenoldopam—Urinary tract infection—Capecitabine—prostate cancer	0.000718	0.00126	CcSEcCtD
Fenoldopam—Back pain—Etoposide—prostate cancer	0.000694	0.00121	CcSEcCtD
Fenoldopam—Muscle spasms—Etoposide—prostate cancer	0.00069	0.00121	CcSEcCtD
Fenoldopam—Haemoglobin—Docetaxel—prostate cancer	0.000688	0.0012	CcSEcCtD
Fenoldopam—Nausea—Ethinyl Estradiol—prostate cancer	0.000688	0.0012	CcSEcCtD
Fenoldopam—Tachycardia—Mitoxantrone—prostate cancer	0.000687	0.0012	CcSEcCtD
Fenoldopam—Haemorrhage—Docetaxel—prostate cancer	0.000685	0.0012	CcSEcCtD
Fenoldopam—Cardiac failure—Epirubicin—prostate cancer	0.000684	0.0012	CcSEcCtD
Fenoldopam—Insomnia—Estradiol—prostate cancer	0.000683	0.0012	CcSEcCtD
Fenoldopam—Hyperhidrosis—Mitoxantrone—prostate cancer	0.00068	0.00119	CcSEcCtD
Fenoldopam—Bradycardia—Capecitabine—prostate cancer	0.000675	0.00118	CcSEcCtD
Fenoldopam—Dyspnoea—Estradiol—prostate cancer	0.000673	0.00118	CcSEcCtD
Fenoldopam—Haemoglobin—Capecitabine—prostate cancer	0.000666	0.00117	CcSEcCtD
Fenoldopam—Haemorrhage—Capecitabine—prostate cancer	0.000663	0.00116	CcSEcCtD
Fenoldopam—Hypotension—Mitoxantrone—prostate cancer	0.000658	0.00115	CcSEcCtD
Fenoldopam—Diarrhoea—Goserelin—prostate cancer	0.000652	0.00114	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Prednisone—prostate cancer	0.000648	0.00114	CcSEcCtD
Fenoldopam—Constipation—Estradiol—prostate cancer	0.000646	0.00113	CcSEcCtD
Fenoldopam—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000646	0.00113	CcSEcCtD
Fenoldopam—Myocardial infarction—Prednisone—prostate cancer	0.000645	0.00113	CcSEcCtD
Fenoldopam—Flushing—Docetaxel—prostate cancer	0.000636	0.00111	CcSEcCtD
Fenoldopam—Cardiac failure—Doxorubicin—prostate cancer	0.000633	0.00111	CcSEcCtD
Fenoldopam—Dizziness—Goserelin—prostate cancer	0.00063	0.0011	CcSEcCtD
Fenoldopam—Dyspnoea—Mitoxantrone—prostate cancer	0.000627	0.0011	CcSEcCtD
Fenoldopam—Blood creatinine increased—Epirubicin—prostate cancer	0.000625	0.00109	CcSEcCtD
Fenoldopam—Dizziness—Conjugated Estrogens—prostate cancer	0.000624	0.00109	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Estradiol—prostate cancer	0.000618	0.00108	CcSEcCtD
Fenoldopam—Flushing—Capecitabine—prostate cancer	0.000615	0.00108	CcSEcCtD
Fenoldopam—Chest pain—Etoposide—prostate cancer	0.000611	0.00107	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Epirubicin—prostate cancer	0.00061	0.00107	CcSEcCtD
Fenoldopam—Hypokalaemia—Epirubicin—prostate cancer	0.000608	0.00106	CcSEcCtD
Fenoldopam—Vomiting—Goserelin—prostate cancer	0.000606	0.00106	CcSEcCtD
Fenoldopam—Constipation—Mitoxantrone—prostate cancer	0.000602	0.00105	CcSEcCtD
Fenoldopam—Bradycardia—Prednisone—prostate cancer	0.000601	0.00105	CcSEcCtD
Fenoldopam—Vomiting—Conjugated Estrogens—prostate cancer	0.0006	0.00105	CcSEcCtD
Fenoldopam—Body temperature increased—Estradiol—prostate cancer	0.000597	0.00105	CcSEcCtD
Fenoldopam—Abdominal pain—Estradiol—prostate cancer	0.000597	0.00105	CcSEcCtD
Fenoldopam—Headache—Goserelin—prostate cancer	0.000597	0.00104	CcSEcCtD
Fenoldopam—Haemoglobin—Prednisone—prostate cancer	0.000594	0.00104	CcSEcCtD
Fenoldopam—Headache—Conjugated Estrogens—prostate cancer	0.000591	0.00103	CcSEcCtD
Fenoldopam—Haemorrhage—Prednisone—prostate cancer	0.000591	0.00103	CcSEcCtD
Fenoldopam—Blood creatinine increased—Doxorubicin—prostate cancer	0.000579	0.00101	CcSEcCtD
Fenoldopam—Back pain—Docetaxel—prostate cancer	0.000577	0.00101	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000575	0.00101	CcSEcCtD
Fenoldopam—Muscle spasms—Docetaxel—prostate cancer	0.000573	0.001	CcSEcCtD
Fenoldopam—Tachycardia—Etoposide—prostate cancer	0.000571	0.001	CcSEcCtD
Fenoldopam—Nausea—Goserelin—prostate cancer	0.000566	0.000991	CcSEcCtD
Fenoldopam—Hyperhidrosis—Etoposide—prostate cancer	0.000566	0.00099	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Doxorubicin—prostate cancer	0.000564	0.000988	CcSEcCtD
Fenoldopam—Hypokalaemia—Doxorubicin—prostate cancer	0.000562	0.000984	CcSEcCtD
Fenoldopam—Angina pectoris—Epirubicin—prostate cancer	0.000562	0.000984	CcSEcCtD
Fenoldopam—Nausea—Conjugated Estrogens—prostate cancer	0.000561	0.000981	CcSEcCtD
Fenoldopam—Back pain—Capecitabine—prostate cancer	0.000558	0.000977	CcSEcCtD
Fenoldopam—Abdominal pain—Mitoxantrone—prostate cancer	0.000556	0.000974	CcSEcCtD
Fenoldopam—Body temperature increased—Mitoxantrone—prostate cancer	0.000556	0.000974	CcSEcCtD
Fenoldopam—Muscle spasms—Capecitabine—prostate cancer	0.000555	0.000971	CcSEcCtD
Fenoldopam—Flushing—Prednisone—prostate cancer	0.000548	0.000959	CcSEcCtD
Fenoldopam—Hypotension—Etoposide—prostate cancer	0.000547	0.000957	CcSEcCtD
Fenoldopam—Palpitations—Docetaxel—prostate cancer	0.000527	0.000922	CcSEcCtD
Fenoldopam—Dyspnoea—Etoposide—prostate cancer	0.000522	0.000913	CcSEcCtD
Fenoldopam—Angina pectoris—Doxorubicin—prostate cancer	0.00052	0.00091	CcSEcCtD
Fenoldopam—Diarrhoea—Estradiol—prostate cancer	0.000517	0.000904	CcSEcCtD
Fenoldopam—Palpitations—Capecitabine—prostate cancer	0.00051	0.000893	CcSEcCtD
Fenoldopam—Chest pain—Docetaxel—prostate cancer	0.000507	0.000888	CcSEcCtD
Fenoldopam—Constipation—Etoposide—prostate cancer	0.000501	0.000876	CcSEcCtD
Fenoldopam—Urinary tract infection—Epirubicin—prostate cancer	0.0005	0.000875	CcSEcCtD
Fenoldopam—Dizziness—Estradiol—prostate cancer	0.000499	0.000874	CcSEcCtD
Fenoldopam—Sweating—Epirubicin—prostate cancer	0.000493	0.000863	CcSEcCtD
Fenoldopam—Chest pain—Capecitabine—prostate cancer	0.000491	0.00086	CcSEcCtD
Fenoldopam—Anxiety—Capecitabine—prostate cancer	0.00049	0.000857	CcSEcCtD
Fenoldopam—Diarrhoea—Mitoxantrone—prostate cancer	0.000482	0.000843	CcSEcCtD
Fenoldopam—Vomiting—Estradiol—prostate cancer	0.00048	0.000841	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Etoposide—prostate cancer	0.000479	0.000838	CcSEcCtD
Fenoldopam—Tachycardia—Docetaxel—prostate cancer	0.000475	0.000831	CcSEcCtD
Fenoldopam—Headache—Estradiol—prostate cancer	0.000473	0.000828	CcSEcCtD
Fenoldopam—Bradycardia—Epirubicin—prostate cancer	0.00047	0.000823	CcSEcCtD
Fenoldopam—Haemoglobin—Epirubicin—prostate cancer	0.000464	0.000812	CcSEcCtD
Fenoldopam—Abdominal pain—Etoposide—prostate cancer	0.000463	0.00081	CcSEcCtD
Fenoldopam—Body temperature increased—Etoposide—prostate cancer	0.000463	0.00081	CcSEcCtD
Fenoldopam—Urinary tract infection—Doxorubicin—prostate cancer	0.000463	0.00081	CcSEcCtD
Fenoldopam—Haemorrhage—Epirubicin—prostate cancer	0.000462	0.000808	CcSEcCtD
Fenoldopam—Tachycardia—Capecitabine—prostate cancer	0.00046	0.000805	CcSEcCtD
Fenoldopam—Sweating—Doxorubicin—prostate cancer	0.000456	0.000799	CcSEcCtD
Fenoldopam—Hyperhidrosis—Capecitabine—prostate cancer	0.000455	0.000797	CcSEcCtD
Fenoldopam—Hypotension—Docetaxel—prostate cancer	0.000455	0.000796	CcSEcCtD
Fenoldopam—Nausea—Estradiol—prostate cancer	0.000449	0.000785	CcSEcCtD
Fenoldopam—Vomiting—Mitoxantrone—prostate cancer	0.000447	0.000783	CcSEcCtD
Fenoldopam—Headache—Mitoxantrone—prostate cancer	0.000441	0.000772	CcSEcCtD
Fenoldopam—Hypotension—Capecitabine—prostate cancer	0.00044	0.00077	CcSEcCtD
Fenoldopam—Insomnia—Docetaxel—prostate cancer	0.00044	0.00077	CcSEcCtD
Fenoldopam—Anxiety—Prednisone—prostate cancer	0.000436	0.000763	CcSEcCtD
Fenoldopam—Bradycardia—Doxorubicin—prostate cancer	0.000435	0.000761	CcSEcCtD
Fenoldopam—Dyspnoea—Docetaxel—prostate cancer	0.000434	0.000759	CcSEcCtD
Fenoldopam—Haemoglobin—Doxorubicin—prostate cancer	0.00043	0.000752	CcSEcCtD
Fenoldopam—Flushing—Epirubicin—prostate cancer	0.000429	0.00075	CcSEcCtD
Fenoldopam—Haemorrhage—Doxorubicin—prostate cancer	0.000427	0.000748	CcSEcCtD
Fenoldopam—Insomnia—Capecitabine—prostate cancer	0.000426	0.000746	CcSEcCtD
Fenoldopam—Dyspnoea—Capecitabine—prostate cancer	0.00042	0.000735	CcSEcCtD
Fenoldopam—Nausea—Mitoxantrone—prostate cancer	0.000418	0.000732	CcSEcCtD
Fenoldopam—Constipation—Docetaxel—prostate cancer	0.000416	0.000728	CcSEcCtD
Fenoldopam—Tachycardia—Prednisone—prostate cancer	0.000409	0.000717	CcSEcCtD
Fenoldopam—Hyperhidrosis—Prednisone—prostate cancer	0.000406	0.00071	CcSEcCtD
Fenoldopam—Constipation—Capecitabine—prostate cancer	0.000403	0.000705	CcSEcCtD
Fenoldopam—Diarrhoea—Etoposide—prostate cancer	0.000401	0.000701	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Docetaxel—prostate cancer	0.000398	0.000696	CcSEcCtD
Fenoldopam—Flushing—Doxorubicin—prostate cancer	0.000397	0.000694	CcSEcCtD
Fenoldopam—Tension—Epirubicin—prostate cancer	0.000395	0.000691	CcSEcCtD
Fenoldopam—Nervousness—Epirubicin—prostate cancer	0.000391	0.000683	CcSEcCtD
Fenoldopam—Back pain—Epirubicin—prostate cancer	0.000389	0.000681	CcSEcCtD
Fenoldopam—Dizziness—Etoposide—prostate cancer	0.000387	0.000678	CcSEcCtD
Fenoldopam—Muscle spasms—Epirubicin—prostate cancer	0.000387	0.000677	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Capecitabine—prostate cancer	0.000385	0.000674	CcSEcCtD
Fenoldopam—Abdominal pain—Docetaxel—prostate cancer	0.000385	0.000673	CcSEcCtD
Fenoldopam—Body temperature increased—Docetaxel—prostate cancer	0.000385	0.000673	CcSEcCtD
Fenoldopam—Insomnia—Prednisone—prostate cancer	0.000379	0.000664	CcSEcCtD
Fenoldopam—Abdominal pain—Capecitabine—prostate cancer	0.000372	0.000652	CcSEcCtD
Fenoldopam—Body temperature increased—Capecitabine—prostate cancer	0.000372	0.000652	CcSEcCtD
Fenoldopam—Vomiting—Etoposide—prostate cancer	0.000372	0.000651	CcSEcCtD
Fenoldopam—Headache—Etoposide—prostate cancer	0.000367	0.000642	CcSEcCtD
Fenoldopam—Tension—Doxorubicin—prostate cancer	0.000365	0.000639	CcSEcCtD
Fenoldopam—Nervousness—Doxorubicin—prostate cancer	0.000361	0.000632	CcSEcCtD
Fenoldopam—Back pain—Doxorubicin—prostate cancer	0.00036	0.00063	CcSEcCtD
Fenoldopam—Constipation—Prednisone—prostate cancer	0.000359	0.000628	CcSEcCtD
Fenoldopam—Muscle spasms—Doxorubicin—prostate cancer	0.000358	0.000626	CcSEcCtD
Fenoldopam—Palpitations—Epirubicin—prostate cancer	0.000355	0.000622	CcSEcCtD
Fenoldopam—Nausea—Etoposide—prostate cancer	0.000348	0.000609	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Prednisone—prostate cancer	0.000343	0.0006	CcSEcCtD
Fenoldopam—Chest pain—Epirubicin—prostate cancer	0.000342	0.000599	CcSEcCtD
Fenoldopam—Anxiety—Epirubicin—prostate cancer	0.000341	0.000597	CcSEcCtD
Fenoldopam—Diarrhoea—Docetaxel—prostate cancer	0.000333	0.000583	CcSEcCtD
Fenoldopam—Body temperature increased—Prednisone—prostate cancer	0.000332	0.00058	CcSEcCtD
Fenoldopam—Abdominal pain—Prednisone—prostate cancer	0.000332	0.00058	CcSEcCtD
Fenoldopam—Palpitations—Doxorubicin—prostate cancer	0.000329	0.000575	CcSEcCtD
Fenoldopam—Diarrhoea—Capecitabine—prostate cancer	0.000322	0.000564	CcSEcCtD
Fenoldopam—Dizziness—Docetaxel—prostate cancer	0.000322	0.000563	CcSEcCtD
Fenoldopam—Tachycardia—Epirubicin—prostate cancer	0.00032	0.000561	CcSEcCtD
Fenoldopam—Hyperhidrosis—Epirubicin—prostate cancer	0.000317	0.000555	CcSEcCtD
Fenoldopam—Chest pain—Doxorubicin—prostate cancer	0.000317	0.000554	CcSEcCtD
Fenoldopam—Anxiety—Doxorubicin—prostate cancer	0.000316	0.000552	CcSEcCtD
Fenoldopam—Dizziness—Capecitabine—prostate cancer	0.000311	0.000545	CcSEcCtD
Fenoldopam—Vomiting—Docetaxel—prostate cancer	0.000309	0.000541	CcSEcCtD
Fenoldopam—Hypotension—Epirubicin—prostate cancer	0.000307	0.000537	CcSEcCtD
Fenoldopam—Headache—Docetaxel—prostate cancer	0.000305	0.000533	CcSEcCtD
Fenoldopam—Vomiting—Capecitabine—prostate cancer	0.000299	0.000524	CcSEcCtD
Fenoldopam—Insomnia—Epirubicin—prostate cancer	0.000297	0.000519	CcSEcCtD
Fenoldopam—Tachycardia—Doxorubicin—prostate cancer	0.000296	0.000519	CcSEcCtD
Fenoldopam—Headache—Capecitabine—prostate cancer	0.000295	0.000516	CcSEcCtD
Fenoldopam—Hyperhidrosis—Doxorubicin—prostate cancer	0.000294	0.000514	CcSEcCtD
Fenoldopam—Dyspnoea—Epirubicin—prostate cancer	0.000293	0.000512	CcSEcCtD
Fenoldopam—Nausea—Docetaxel—prostate cancer	0.000289	0.000506	CcSEcCtD
Fenoldopam—Diarrhoea—Prednisone—prostate cancer	0.000287	0.000502	CcSEcCtD
Fenoldopam—Hypotension—Doxorubicin—prostate cancer	0.000284	0.000497	CcSEcCtD
Fenoldopam—Constipation—Epirubicin—prostate cancer	0.000281	0.000491	CcSEcCtD
Fenoldopam—Nausea—Capecitabine—prostate cancer	0.00028	0.00049	CcSEcCtD
Fenoldopam—Dizziness—Prednisone—prostate cancer	0.000277	0.000486	CcSEcCtD
Fenoldopam—Insomnia—Doxorubicin—prostate cancer	0.000275	0.000481	CcSEcCtD
Fenoldopam—Dyspnoea—Doxorubicin—prostate cancer	0.000271	0.000474	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Epirubicin—prostate cancer	0.000268	0.00047	CcSEcCtD
Fenoldopam—Vomiting—Prednisone—prostate cancer	0.000267	0.000467	CcSEcCtD
Fenoldopam—Headache—Prednisone—prostate cancer	0.000263	0.00046	CcSEcCtD
Fenoldopam—Constipation—Doxorubicin—prostate cancer	0.00026	0.000454	CcSEcCtD
Fenoldopam—Body temperature increased—Epirubicin—prostate cancer	0.000259	0.000454	CcSEcCtD
Fenoldopam—Abdominal pain—Epirubicin—prostate cancer	0.000259	0.000454	CcSEcCtD
Fenoldopam—Nausea—Prednisone—prostate cancer	0.000249	0.000436	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000248	0.000435	CcSEcCtD
Fenoldopam—Body temperature increased—Doxorubicin—prostate cancer	0.00024	0.00042	CcSEcCtD
Fenoldopam—Abdominal pain—Doxorubicin—prostate cancer	0.00024	0.00042	CcSEcCtD
Fenoldopam—Diarrhoea—Epirubicin—prostate cancer	0.000225	0.000393	CcSEcCtD
Fenoldopam—Dizziness—Epirubicin—prostate cancer	0.000217	0.00038	CcSEcCtD
Fenoldopam—Vomiting—Epirubicin—prostate cancer	0.000209	0.000365	CcSEcCtD
Fenoldopam—Diarrhoea—Doxorubicin—prostate cancer	0.000208	0.000364	CcSEcCtD
Fenoldopam—Headache—Epirubicin—prostate cancer	0.000206	0.00036	CcSEcCtD
Fenoldopam—Dizziness—Doxorubicin—prostate cancer	0.000201	0.000351	CcSEcCtD
Fenoldopam—Nausea—Epirubicin—prostate cancer	0.000195	0.000341	CcSEcCtD
Fenoldopam—Vomiting—Doxorubicin—prostate cancer	0.000193	0.000338	CcSEcCtD
Fenoldopam—Headache—Doxorubicin—prostate cancer	0.00019	0.000333	CcSEcCtD
Fenoldopam—Nausea—Doxorubicin—prostate cancer	0.00018	0.000316	CcSEcCtD
Fenoldopam—DRD1—Signaling Pathways—CTNNB1—prostate cancer	1.35e-05	5.06e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCND1—prostate cancer	1.34e-05	5.04e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CG—prostate cancer	1.34e-05	5.03e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APC—prostate cancer	1.34e-05	5.03e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CREBBP—prostate cancer	1.34e-05	5.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—JAK2—prostate cancer	1.33e-05	5e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—NOS3—prostate cancer	1.33e-05	5e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CTNNB1—prostate cancer	1.33e-05	4.99e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MAP2K1—prostate cancer	1.33e-05	4.98e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EGF—prostate cancer	1.33e-05	4.98e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IRS1—prostate cancer	1.33e-05	4.98e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IGF1—prostate cancer	1.32e-05	4.96e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MMP9—prostate cancer	1.32e-05	4.96e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CD—prostate cancer	1.32e-05	4.94e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CDKN1A—prostate cancer	1.32e-05	4.94e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—EGFR—prostate cancer	1.31e-05	4.94e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PTEN—prostate cancer	1.31e-05	4.93e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—JAK2—prostate cancer	1.31e-05	4.92e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PTEN—prostate cancer	1.31e-05	4.91e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—PIK3CA—prostate cancer	1.31e-05	4.9e-05	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—PIK3CA—prostate cancer	1.3e-05	4.9e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MMP9—prostate cancer	1.3e-05	4.9e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SERPINE1—prostate cancer	1.3e-05	4.89e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CXCL8—prostate cancer	1.3e-05	4.89e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MDM2—prostate cancer	1.3e-05	4.88e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CDKN1A—prostate cancer	1.3e-05	4.88e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PTEN—prostate cancer	1.3e-05	4.87e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—KRAS—prostate cancer	1.29e-05	4.84e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—GSK3B—prostate cancer	1.29e-05	4.83e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—PIK3CA—prostate cancer	1.28e-05	4.82e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ERBB2—prostate cancer	1.28e-05	4.81e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—AKT1—prostate cancer	1.28e-05	4.81e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MDM2—prostate cancer	1.28e-05	4.8e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MAP2K1—prostate cancer	1.28e-05	4.8e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CDKN1B—prostate cancer	1.27e-05	4.77e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—INS—prostate cancer	1.27e-05	4.77e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CD—prostate cancer	1.27e-05	4.76e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CB—prostate cancer	1.26e-05	4.75e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—AKT1—prostate cancer	1.26e-05	4.75e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ERBB2—prostate cancer	1.26e-05	4.74e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—FGF2—prostate cancer	1.26e-05	4.73e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—AKT1—prostate cancer	1.26e-05	4.72e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—PIK3CA—prostate cancer	1.26e-05	4.72e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SERPINE1—prostate cancer	1.25e-05	4.71e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EP300—prostate cancer	1.25e-05	4.7e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—EP300—prostate cancer	1.25e-05	4.68e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CASP3—prostate cancer	1.25e-05	4.68e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CB—prostate cancer	1.24e-05	4.67e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL2—prostate cancer	1.24e-05	4.67e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOS3—prostate cancer	1.24e-05	4.67e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CREBBP—prostate cancer	1.24e-05	4.67e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—KRAS—prostate cancer	1.24e-05	4.66e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL6—prostate cancer	1.24e-05	4.65e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EP300—prostate cancer	1.24e-05	4.64e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL6—prostate cancer	1.23e-05	4.64e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CB—prostate cancer	1.23e-05	4.61e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IGF1—prostate cancer	1.23e-05	4.61e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—EGFR—prostate cancer	1.22e-05	4.59e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SRC—prostate cancer	1.22e-05	4.57e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTGS2—prostate cancer	1.22e-05	4.57e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CXCL8—prostate cancer	1.22e-05	4.56e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—FGF2—prostate cancer	1.21e-05	4.56e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCND1—prostate cancer	1.21e-05	4.55e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—JAK2—prostate cancer	1.21e-05	4.54e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SRC—prostate cancer	1.2e-05	4.51e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CTNNB1—prostate cancer	1.2e-05	4.51e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOS3—prostate cancer	1.2e-05	4.5e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CXCL8—prostate cancer	1.2e-05	4.49e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CDKN1B—prostate cancer	1.19e-05	4.46e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAP2K1—prostate cancer	1.19e-05	4.46e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—VEGFA—prostate cancer	1.19e-05	4.45e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—PIK3CA—prostate cancer	1.18e-05	4.45e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MDM2—prostate cancer	1.18e-05	4.43e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CD—prostate cancer	1.18e-05	4.43e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MMP9—prostate cancer	1.18e-05	4.42e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—STAT3—prostate cancer	1.17e-05	4.41e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AKT1—prostate cancer	1.17e-05	4.41e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CDKN1A—prostate cancer	1.17e-05	4.4e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—VEGFA—prostate cancer	1.17e-05	4.4e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PTEN—prostate cancer	1.17e-05	4.39e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CDKN1B—prostate cancer	1.17e-05	4.39e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—PIK3CA—prostate cancer	1.17e-05	4.38e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SERPINE1—prostate cancer	1.17e-05	4.38e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—JAK2—prostate cancer	1.16e-05	4.37e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CASP3—prostate cancer	1.16e-05	4.37e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ERBB2—prostate cancer	1.16e-05	4.37e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL2—prostate cancer	1.16e-05	4.36e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—STAT3—prostate cancer	1.16e-05	4.35e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL6—prostate cancer	1.16e-05	4.34e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AKT1—prostate cancer	1.16e-05	4.34e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—KRAS—prostate cancer	1.15e-05	4.33e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CB—prostate cancer	1.15e-05	4.31e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CASP3—prostate cancer	1.14e-05	4.3e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL2—prostate cancer	1.14e-05	4.29e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AKT1—prostate cancer	1.14e-05	4.29e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—PIK3CA—prostate cancer	1.14e-05	4.28e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AKT1—prostate cancer	1.14e-05	4.28e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL6—prostate cancer	1.14e-05	4.27e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MDM2—prostate cancer	1.14e-05	4.27e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCND1—prostate cancer	1.13e-05	4.25e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—FGF2—prostate cancer	1.13e-05	4.24e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CTNNB1—prostate cancer	1.12e-05	4.21e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ERBB2—prostate cancer	1.12e-05	4.21e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EP300—prostate cancer	1.12e-05	4.19e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCND1—prostate cancer	1.11e-05	4.18e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOS3—prostate cancer	1.11e-05	4.18e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CB—prostate cancer	1.11e-05	4.15e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CTNNB1—prostate cancer	1.1e-05	4.14e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CXCL8—prostate cancer	1.1e-05	4.14e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MMP9—prostate cancer	1.1e-05	4.13e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CDKN1A—prostate cancer	1.1e-05	4.11e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PTEN—prostate cancer	1.09e-05	4.1e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MYC—prostate cancer	1.09e-05	4.1e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TGFB1—prostate cancer	1.09e-05	4.09e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SRC—prostate cancer	1.08e-05	4.07e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MMP9—prostate cancer	1.08e-05	4.06e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—JAK2—prostate cancer	1.08e-05	4.06e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CDKN1A—prostate cancer	1.08e-05	4.05e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MYC—prostate cancer	1.08e-05	4.04e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CDKN1B—prostate cancer	1.08e-05	4.04e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PTEN—prostate cancer	1.08e-05	4.04e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TGFB1—prostate cancer	1.07e-05	4.03e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EGFR—prostate cancer	1.07e-05	4.01e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AKT1—prostate cancer	1.07e-05	4e-05	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AKT1—prostate cancer	1.07e-05	4e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CXCL8—prostate cancer	1.06e-05	3.99e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTEN—prostate cancer	1.06e-05	3.99e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—PIK3CA—prostate cancer	1.06e-05	3.98e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—VEGFA—prostate cancer	1.06e-05	3.97e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MDM2—prostate cancer	1.06e-05	3.97e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CASP3—prostate cancer	1.06e-05	3.96e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL2—prostate cancer	1.05e-05	3.96e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EGFR—prostate cancer	1.05e-05	3.96e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AKT1—prostate cancer	1.05e-05	3.94e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL6—prostate cancer	1.05e-05	3.94e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—STAT3—prostate cancer	1.05e-05	3.93e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EP300—prostate cancer	1.04e-05	3.91e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ERBB2—prostate cancer	1.04e-05	3.91e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CDKN1B—prostate cancer	1.04e-05	3.9e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCND1—prostate cancer	1.03e-05	3.86e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CB—prostate cancer	1.03e-05	3.86e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AKT1—prostate cancer	1.03e-05	3.85e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EP300—prostate cancer	1.03e-05	3.85e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CTNNB1—prostate cancer	1.02e-05	3.82e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CASP3—prostate cancer	1.02e-05	3.82e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL2—prostate cancer	1.02e-05	3.81e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SRC—prostate cancer	1.01e-05	3.81e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—EP300—prostate cancer	1.01e-05	3.8e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL6—prostate cancer	1.01e-05	3.79e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—KRAS—prostate cancer	1.01e-05	3.79e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SRC—prostate cancer	9.97e-06	3.75e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MMP9—prostate cancer	9.97e-06	3.75e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—KRAS—prostate cancer	9.95e-06	3.74e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CDKN1A—prostate cancer	9.94e-06	3.73e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PTEN—prostate cancer	9.92e-06	3.72e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCND1—prostate cancer	9.9e-06	3.72e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CXCL8—prostate cancer	9.87e-06	3.71e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—VEGFA—prostate cancer	9.87e-06	3.71e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CTNNB1—prostate cancer	9.8e-06	3.68e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—STAT3—prostate cancer	9.77e-06	3.67e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MYC—prostate cancer	9.72e-06	3.65e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—VEGFA—prostate cancer	9.71e-06	3.65e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TGFB1—prostate cancer	9.7e-06	3.64e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AKT1—prostate cancer	9.67e-06	3.63e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	9.64e-06	3.62e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—STAT3—prostate cancer	9.62e-06	3.61e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MMP9—prostate cancer	9.61e-06	3.61e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	9.57e-06	3.6e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PTEN—prostate cancer	9.55e-06	3.59e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	9.54e-06	3.58e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EGFR—prostate cancer	9.51e-06	3.57e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EP300—prostate cancer	9.46e-06	3.55e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CASP3—prostate cancer	9.45e-06	3.55e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL2—prostate cancer	9.43e-06	3.54e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL6—prostate cancer	9.39e-06	3.53e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	9.32e-06	3.5e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PIK3CA—prostate cancer	9.27e-06	3.48e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PIK3CA—prostate cancer	9.22e-06	3.46e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCND1—prostate cancer	9.2e-06	3.45e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SRC—prostate cancer	9.2e-06	3.45e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PIK3CA—prostate cancer	9.14e-06	3.43e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EP300—prostate cancer	9.11e-06	3.42e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	9.11e-06	3.42e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MYC—prostate cancer	9.08e-06	3.41e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TGFB1—prostate cancer	9.06e-06	3.4e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—KRAS—prostate cancer	8.98e-06	3.37e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TP53—prostate cancer	8.96e-06	3.37e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—VEGFA—prostate cancer	8.96e-06	3.36e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MYC—prostate cancer	8.94e-06	3.36e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MMP9—prostate cancer	8.93e-06	3.35e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TGFB1—prostate cancer	8.92e-06	3.35e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	8.9e-06	3.34e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EGFR—prostate cancer	8.88e-06	3.34e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PTEN—prostate cancer	8.88e-06	3.33e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—STAT3—prostate cancer	8.87e-06	3.33e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SRC—prostate cancer	8.86e-06	3.33e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TP53—prostate cancer	8.84e-06	3.32e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EGFR—prostate cancer	8.74e-06	3.28e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	8.66e-06	3.25e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	8.63e-06	3.24e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—STAT3—prostate cancer	8.54e-06	3.21e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EP300—prostate cancer	8.47e-06	3.18e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—KRAS—prostate cancer	8.39e-06	3.15e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—KRAS—prostate cancer	8.26e-06	3.1e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CA—prostate cancer	8.25e-06	3.1e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MYC—prostate cancer	8.24e-06	3.09e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SRC—prostate cancer	8.23e-06	3.09e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TGFB1—prostate cancer	8.22e-06	3.09e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL6—prostate cancer	8.2e-06	3.08e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL6—prostate cancer	8.1e-06	3.04e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EGFR—prostate cancer	8.06e-06	3.03e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	8.02e-06	3.01e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TP53—prostate cancer	7.98e-06	3e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MYC—prostate cancer	7.94e-06	2.98e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—STAT3—prostate cancer	7.94e-06	2.98e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	7.92e-06	2.97e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EGFR—prostate cancer	7.77e-06	2.92e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CA—prostate cancer	7.71e-06	2.9e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KRAS—prostate cancer	7.61e-06	2.86e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CA—prostate cancer	7.59e-06	2.85e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AKT1—prostate cancer	7.57e-06	2.84e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—AKT1—prostate cancer	7.53e-06	2.83e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CA—prostate cancer	7.49e-06	2.81e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AKT1—prostate cancer	7.47e-06	2.8e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TP53—prostate cancer	7.46e-06	2.8e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MYC—prostate cancer	7.38e-06	2.77e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	7.36e-06	2.76e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TP53—prostate cancer	7.34e-06	2.76e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KRAS—prostate cancer	7.34e-06	2.75e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL6—prostate cancer	7.31e-06	2.74e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EGFR—prostate cancer	7.21e-06	2.71e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CA—prostate cancer	7e-06	2.63e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6—prostate cancer	6.83e-06	2.56e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KRAS—prostate cancer	6.82e-06	2.56e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TP53—prostate cancer	6.77e-06	2.54e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AKT1—prostate cancer	6.74e-06	2.53e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	6.74e-06	2.53e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6—prostate cancer	6.72e-06	2.52e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TP53—prostate cancer	6.52e-06	2.45e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKT1—prostate cancer	6.3e-06	2.37e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	6.26e-06	2.35e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKT1—prostate cancer	6.2e-06	2.33e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6—prostate cancer	6.19e-06	2.33e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—AKT1—prostate cancer	6.12e-06	2.3e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TP53—prostate cancer	6.06e-06	2.28e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6—prostate cancer	5.97e-06	2.24e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKT1—prostate cancer	5.71e-06	2.15e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6—prostate cancer	5.54e-06	2.08e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKT1—prostate cancer	5.51e-06	2.07e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT1—prostate cancer	5.12e-06	1.92e-05	CbGpPWpGaD
